Experience with levosimendan in 32 paediatric patients

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Critical Care Medicine

Background:

• Levosimendan is a calcium sensitizer used for heart failure.
• Its off-label use in pediatric populations requires further investigation.
• Understanding usage patterns and safety is crucial for optimizing pediatric cardiac care.

Purpose of the Study:

• To describe the off-label use of levosimendan in pediatric patients.
• To evaluate the safety and efficacy of levosimendan in this population.
• To identify factors contributing to levosimendan's tolerance in children.

Main Methods:

• Retrospective observational study (January 2007-January 2014).
• Included 32 pediatric patients receiving intravenous levosimendan.
• Data collected included demographics, diagnosis, dosage, duration, concomitant treatments, side effects, and survival.

Main Results:

• 32 pediatric patients received 70 levosimendan infusions.
• 46.9% of patients received repeat doses.
• Levosimendan was well-tolerated, with only one case of severe hypotension; no severe side effects were registered.

Conclusions:

• Levosimendan is a safe and effective off-label treatment strategy in the pediatric population.
• The absence of loading doses may contribute to good tolerance.
• Further research is warranted to establish optimal dosing and indications.